You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 244 No. 15, October 10, 1980 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Potency of Brand Name and Generic Levothyroxine Products

Sheldon S. Stoffer, MD; Walter E. Szpunar, PhD

JAMA. 1980;244(15):1704-1705.


Abstract

The tablet thyroxine content of a brand name and two generic products were studied. The mean thyroxine content was significantly different in the generic tablets when compared with that in the brand name product. The coefficient of variation of tablet thyroxine was lowest in the brand name, although this product had only 78% of expected potency. When these products were tested in three hypothyroid patients, two serum free thyroxine indexes were well outside the normal range when the most potent generic product was substituted for the brand name drug. Manufacturers should be required to measure the thyroxine content of their tablets. Until such time that levothyroxine products become more uniform, physicians, pharmacists, and legislators should not encourage product switching.

(JAMA 244:1704-1705, 1980)



Author Affiliations

From the Associated Endocrinologists-Northland Thyroid Laboratory, Southland, Mich.


Footnotes

Reprint requests to Associated Endocrinologists-Northland Thyroid Laboratory, 4400 Prudential Town Center, Suite 275, Southfield, MI 48075 (Dr Stoffer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evidence of Hyperthyroidism in Apparently Euthyroid Patients Treated With Levothyroxine
Banovac et al.
Arch Intern Med 1989;149:809-812.
ABSTRACT  

Levothyroxine Loses Potency With Age
Stoffer and Szpunar
JAMA 1986;255:1881-1882.
ABSTRACT  

The Equivalency of Two L-Thyroxine Preparations
HENNESSEY et al.
ANN INTERN MED 1985;102:770-773.
ABSTRACT  

Oral Thyroxine
BOEHLER
ANN INTERN MED 1984;101:572-573.
ABSTRACT  

Thyroxine Preparations
HENNESSEY and WARTOFSKY
ANN INTERN MED 1984;101:140-141.
ABSTRACT  

Oral Thyroxine: Variation in Biologic Action and Tablet Content
SAWIN et al.
ANN INTERN MED 1984;100:641-645.
ABSTRACT  

Potency of Levothyroxine Products
Stoffer and Szpunar
JAMA 1984;251:635-636.
ABSTRACT  

In Vivo Comparison of Levothyroxine Preparations
Ramos-Gabatin et al.
JAMA 1982;247:203-205.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.